Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rectal Neoplasms 1Pleuropulmonary blastoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1

Interventions

X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Nuclear Medicine Department, Hospital 5Cyclophosphamide 5fludarabine 4Temozolomide 4Carboplatin 4Biopsy 4Oxaliplatin 3Nivolumab 3Melphalan 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vemurafenib 2Topotecan 2Thiotepa 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Gene Rearrangement × Gastrointestinal × Clear all
NCT01353300 2016-07-11

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Children's Oncology Group

Completed
31 enrolled
CNSGastrointestinalGenitourinarySarcoma

Pleuropulmonary blastoma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡